Nektar Therapeutics
NKTR
$56.90
-$2.02-3.43%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -35.15% | -24.41% | -15.94% | -34.39% | -33.75% |
| Total Receivables | -53.40% | -68.45% | -28.55% | -38.10% | -25.05% |
| Inventory | -- | -- | -- | -- | -30.08% |
| Prepaid Expenses | -27.03% | -46.92% | -43.05% | -50.80% | -37.57% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 79.85% | 54.37% | -54.98% | 1,737.79% | 29.07% |
| Total Current Assets | -36.80% | -28.12% | -20.99% | -28.20% | -33.07% |
|
|
|||||
| Total Current Assets | -36.80% | -28.12% | -20.99% | -28.20% | -33.07% |
| Net Property, Plant & Equipment | -56.72% | -67.87% | -67.92% | -67.88% | -52.63% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 16.46% | 15.79% | 0.06% | -0.09% | 161.14% |
| Total Assets | -39.55% | -35.29% | -23.66% | -30.36% | -30.54% |
|
|
|||||
| Total Accounts Payable | 120.56% | 103.65% | 17.38% | 160.86% | 147.23% |
| Total Accrued Expenses | 21.67% | 42.66% | 42.12% | 28.97% | 21.18% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.16% | 12.77% | 3.16% | 12.62% | 12.70% |
| Total Finance Division Other Current Liabilities | -2.44% | -35.10% | -8.38% | 17.09% | -55.57% |
| Total Other Current Liabilities | -2.44% | -35.10% | -8.38% | 17.09% | -55.57% |
| Total Current Liabilities | 24.54% | 35.35% | 19.76% | 29.69% | 13.08% |
|
|
|||||
| Total Current Liabilities | 24.54% | 35.35% | 19.76% | 29.69% | 13.08% |
| Long-Term Debt | -25.05% | -26.76% | -18.51% | -20.86% | -20.75% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -18.31% | -17.12% | -16.06% | -15.10% | -14.23% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -30.00% | 55.88% | 56.22% | 39.33% | 56.30% |
| Total Liabilities | -12.10% | -9.95% | -8.96% | -8.41% | -11.33% |
|
|
|||||
| Common Stock & APIC | 0.49% | 0.54% | 1.43% | 1.50% | 1.58% |
| Retained Earnings | -3.43% | -3.79% | -3.42% | -4.90% | -5.22% |
| Treasury Stock & Other | 13.74% | 12.99% | -3,773.75% | 58.36% | 45.83% |
| Total Common Equity | -130.38% | -89.16% | -53.63% | -69.33% | -59.54% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -130.38% | -89.16% | -53.63% | -69.33% | -59.54% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -130.38% | -89.16% | -53.63% | -69.33% | -59.54% |
|
|
|||||